1,3-Dipolar cycloaddition reactions of
jhet2543-eo-0001">N-cyclohexyl maleimide (
jhet2543-eo-0001" rel="references:#jhet2543-eo-0001">) with azomethine
N-oxide (
jhet2543-eo-0002" rel="references:#jhet2543-eo-0002">) have afforded novel isoxazolidine (
jhet2543-eo-0003" rel="references:#jhet2543-eo-0003">) in excellent yield. T
heir structures have been characterized from t
heir IR,
1H-NMR,
13C-NMR,
1H,
1H-COSY, MS(ESI), and elemental analysis techniques.
In vitro antibacterial activity of t
he synt
hesized compounds were investigated against a representative panel of pathogenic strains specifically two Gram-positive bacteria (
Staphylococcus aureus and
Streptococcus pyogenes) and two Gram-negative bacteria (
Pseudomonas aeruginosa and
Escherichia coli) using agar-well diffusion assay. Some of t
he compounds (
jhet2543-eo-0004" rel="references:#jhet2543-eo-0004">,
jhet2543-eo-0014" rel="references:#jhet2543-eo-0014">,
jhet2543-eo-0017" rel="references:#jhet2543-eo-0017">, and
jhet2543-eo-0018" rel="references:#jhet2543-eo-0018">) exhibited promising antibacterial activities. All t
he synt
hesized compounds have also been screened for t
heir antioxidant activities and were found to be significantly active.